Annual EBITDA
-$99.06M$34.92M-54.43%
Summary
- Current Value
- As of today, ACLX annual EBITDA is -$99.06M, down -54.43% on
- Historical Performance
- ACLX annual EBITDA is down -54.98% over the past 3 years, and down -461.32% over the past 5 years
- All-Time High Comparison
- ACLX annual EBITDA is currently -461.32% below its historical high of -$17.65M set on
- 3-Year Low Comparison
- ACLX annual EBITDA is +46.64% above its 3-year low of -$185.64M reached on an earlier date
- Sector Comparison
- ACLX annual EBITDA is higher than 17.28% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$99.06M | -54.4% | -55.0% | -461.3% | -461.3% | |
| Quarterly EBITDA | -$59.93M | -85.7% | +35.7% | -571.2% | -571.2% | |
| TTM EBITDA | -$235.73M | -261.0% | -38.6% | -2540.0% | -2540.0% | |
| Price | $67.23 | +2.8% | +103.7% | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $107.94M | -2.2% | +100.0% | +100.0% | +100.0% | |
| Annual EPS | -$2.00 | -36.3% | -10.2% | -287.9% | -287.9% | |
| Annual EBIT | -$104.25M | -57.5% | -60.5% | -480.0% | -480.0% | |
| Annual Net Income | -$107.35M | -51.9% | -65.2% | -497.3% | -497.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$64.15M | -54.4% | |
| 5Y | -$31.47M | N/A | -214.8% |
| All | -$17.65M | -461.3% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$185.64M | N/A | +46.6% |
| 5Y | -$185.64M | +46.6% | |
| All | -$185.64M | +46.6% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$99.06M | -54.4% | |
| -$64.15M | +65.4% | |
| -$185.64M | -190.4% |
| Year | Value | Change |
|---|---|---|
| -$63.92M | -103.1% | |
| -$31.47M | -78.3% | |
| -$17.65M | - |
FAQ
What is the current annual EBITDA of ACLX?
As of today, ACLX annual EBITDA is -$99.06M
What is 1-year change in ACLX annual EBITDA?
ACLX annual EBITDA is down -54.43% year-over-year
What is 3-year change in ACLX annual EBITDA?
ACLX annual EBITDA is down -54.98% over the past 3 years
How far is ACLX annual EBITDA from its all-time high?
ACLX annual EBITDA is currently -461.32% below its historical high of -$17.65M set on December 31, 2019
How does ACLX annual EBITDA rank versus sector peers?
ACLX annual EBITDA is higher than 17.28% of companies in Healthcare sector
When is ACLX next annual earnings release?
The next annual earnings release for ACLX is on
Quarterly EBITDA
-$59.93M$2.83M-4.95%
Summary
- Current Value
- As of today, ACLX quarterly EBITDA is -$59.93M, down -4.95% on
- Historical Performance
- ACLX quarterly EBITDA is down -85.65% year-over-year, and up +35.70% over the past 3 years
- All-Time High Comparison
- ACLX quarterly EBITDA is currently -481.23% below its historical high of $15.72M set on
- 3-Year Low Comparison
- ACLX quarterly EBITDA is +10.98% above its 3-year low of -$67.32M reached on
- Sector Comparison
- ACLX quarterly EBITDA is higher than 5.89% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$59.93M | -5.0% | -85.7% | +35.7% | -571.2% | |
| Annual EBITDA | -$99.06M | – | -54.4% | -55.0% | -461.3% | |
| TTM EBITDA | -$235.73M | -13.3% | -261.0% | -38.6% | -2540.0% | |
| Price | $67.23 | -20.0% | +2.8% | +103.7% | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $4.95M | -34.5% | -81.0% | +100.0% | +100.0% | |
| Quarterly EPS | -$0.99 | -5.0% | -105.1% | +53.5% | -263.6% | |
| Quarterly EBIT | -$61.78M | -5.2% | -83.8% | +34.2% | -579.3% | |
| Quarterly Net Income | -$55.78M | -5.7% | -115.7% | +39.9% | -513.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$51.36M | N/A | -16.7% |
| 3Y | $15.72M | -481.2% | |
| 5Y | $15.72M | -481.2% | |
| All | $15.72M | -481.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$67.32M | +11.0% | |
| 3Y | -$67.32M | +11.0% | |
| 5Y | -$93.22M | +35.7% | |
| All | -$93.22M | +35.7% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ACLX?
As of today, ACLX quarterly EBITDA is -$59.93M
What is ACLX quarterly EBITDA most recent change?
ACLX quarterly EBITDA was down -4.95% on September 30, 2025
What is 1-year change in ACLX quarterly EBITDA?
ACLX quarterly EBITDA is down -85.65% year-over-year
How far is ACLX quarterly EBITDA from its all-time high?
ACLX quarterly EBITDA is currently -481.23% below its historical high of $15.72M set on December 31, 2023
How does ACLX quarterly EBITDA rank versus sector peers?
ACLX quarterly EBITDA is higher than 5.89% of companies in Healthcare sector
When is ACLX next earnings release?
The next earnings release for ACLX is on
TTM EBITDA
-$235.73M$27.65M-13.29%
Summary
- Current Value
- As of today, ACLX TTM EBITDA is -$235.73M, down -13.29% on
- Historical Performance
- ACLX TTM EBITDA is down -260.99% year-over-year, and down -38.56% over the past 3 years
- All-Time High Comparison
- ACLX TTM EBITDA is currently -2540.00% below its historical high of -$8.93M set on
- 3-Year Low Comparison
- ACLX TTM EBITDA is at its 3-year low
- Sector Comparison
- ACLX TTM EBITDA is higher than 5.62% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$235.73M | -13.3% | -261.0% | -38.6% | -2540.0% | |
| Annual EBITDA | -$99.06M | – | -54.4% | -55.0% | -461.3% | |
| Quarterly EBITDA | -$59.93M | -5.0% | -85.7% | +35.7% | -571.2% | |
| Price | $67.23 | -20.0% | +2.8% | +103.7% | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $35.90M | -37.0% | -77.0% | +100.0% | +100.0% | |
| TTM EPS | -$3.92 | -14.8% | -425.5% | +5.1% | -1345.4% | |
| TTM EBIT | -$242.55M | -13.1% | -249.4% | -41.1% | -2567.2% | |
| TTM Net Income | -$217.90M | -15.9% | -439.1% | -27.9% | -2296.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$132.38M | N/A | -78.1% |
| 3Y | -$65.30M | -261.0% | |
| 5Y | -$8.93M | N/A | -2540.0% |
| All | -$8.93M | -2540.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$235.73M | at low | |
| 3Y | -$235.73M | at low | |
| 5Y | -$235.73M | at low | |
| All | -$235.73M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ACLX?
As of today, ACLX TTM EBITDA is -$235.73M
What is ACLX TTM EBITDA most recent change?
ACLX TTM EBITDA was down -13.29% on September 30, 2025
What is 1-year change in ACLX TTM EBITDA?
ACLX TTM EBITDA is down -260.99% year-over-year
How far is ACLX TTM EBITDA from its all-time high?
ACLX TTM EBITDA is currently -2540.00% below its historical high of -$8.93M set on December 31, 2020
How does ACLX TTM EBITDA rank versus sector peers?
ACLX TTM EBITDA is higher than 5.62% of companies in Healthcare sector
When is ACLX next earnings release?
The next earnings release for ACLX is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- ACLX Official Website www.arcellx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1786205/000119312525266932/0001193125-25-266932-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1786205/000095017025029150/0000950170-25-029150-index.htm
- ACLX Profile on Yahoo Finance finance.yahoo.com/quote/ACLX
- ACLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aclx